VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 188 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50 | -21.9% | 11,684 | +20.2% | 0.00% | – |
Q2 2023 | $64 | +255.6% | 9,718 | +263.0% | 0.00% | – |
Q1 2023 | $18 | -33.3% | 2,677 | -27.1% | 0.00% | – |
Q4 2022 | $27 | -99.9% | 3,672 | 0.0% | 0.00% | – |
Q3 2022 | $36,000 | -10.0% | 3,672 | 0.0% | 0.00% | – |
Q2 2022 | $40,000 | -2.4% | 3,672 | 0.0% | 0.00% | – |
Q1 2022 | $41,000 | -29.3% | 3,672 | -0.8% | 0.00% | – |
Q4 2021 | $58,000 | +5.5% | 3,700 | +14.9% | 0.00% | – |
Q3 2021 | $55,000 | -27.6% | 3,219 | -9.2% | 0.00% | – |
Q2 2021 | $76,000 | +43.4% | 3,547 | 0.0% | 0.00% | – |
Q1 2021 | $53,000 | +60.6% | 3,547 | +37.3% | 0.00% | – |
Q4 2020 | $33,000 | +371.4% | 2,584 | +231.7% | 0.00% | – |
Q3 2020 | $7,000 | -82.9% | 779 | -78.4% | 0.00% | – |
Q2 2020 | $41,000 | -40.6% | 3,601 | -46.0% | 0.00% | – |
Q1 2020 | $69,000 | +40.8% | 6,663 | +122.1% | 0.00% | – |
Q4 2019 | $49,000 | +188.2% | 3,000 | +131.5% | 0.00% | – |
Q3 2019 | $17,000 | – | 1,296 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |